What is the Evolent Health Inc. stock price forecast?

Evolent Health Inc. is currently trading at $4.80. View real-time AI analysis on Alpha Lenz.

What is Evolent Health Inc. insider trading activity?

View the latest insider trading data for Evolent Health Inc. on Alpha Lenz.

What is Evolent Health Inc.'s P/E ratio?

Evolent Health Inc.'s P/E ratio is -1.0.

Evolent Health Inc.

NYSE · EVH

$4.80+0.22(+4.80%)Pre-market

Ask about Evolent Health Inc.'s future dividend policy...

Alpha Chat Insight

“Evolent Health Inc. trades at a P/E of -1.0 (undervalued) with modest ROE of -75.5%. 3Y revenue CAGR of 11.5% highlights clear growth momentum.”

Ask for details →

Company Overview

Evolent Health Inc. is a healthcare solutions company that partners with healthcare providers to enhance patient care through innovative technology and services. Primarily focused on driving value-based care, Evolent Health provides a comprehensive platform integrating clinical and administrative tools designed to improve patient outcomes while reducing the costs associated with healthcare delivery. The company serves a wide array of clients, including hospitals, health systems, and physician organizations, helping them navigate the transition from fee-for-service to value-based care models. Evolent's services encompass a range of areas such as population health management, analytics, and care coordination. Founded in 2011 and headquartered in Arlington, Virginia, Evolent Health holds a significant position within the healthcare sector by enabling institutions to implement personalized and efficient care strategies. Its role in the financial market is underscored by the growing emphasis on cost-effective health management, making it a key player in addressing evolving healthcare trends and policies.

CEOMr. Seth Barrie Blackley

Websitehttps://www.evolent.com

SectorHealthcare

IndustryHealth Information Services

Employees4,500

Company Statistics

FY 2025

Profile

$548.20MMarket Cap

$1.88BRevenue

0.00Shares Out

4,500Employees

Margins

21.31%Gross

4.53%EBITDA

-1.06%Operating

-28.50%Pre-Tax

-28.49%Net

Valuation

-1.03P/E

1.32P/B

0.29EV/Sales

16.30EV/EBITDA

115.29P/FCF

Growth (CAGR)

11.54%Rev 3Yr

15.20%Rev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

-24.06%ROA

-75.47%ROE

-21.48%ROIC

Financial Health

$151.86MCash & Cash Equivalents

$1.33BNet Debt

357.43%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Evolent Health Inc. trades at a P/E of -1.0 (undervalued) with modest ROE of -75.5%. 3Y revenue CAGR of 11.5% highlights clear growth momentum.”

Ask for details →

Frequently Asked Questions

Evolent Health Inc. (ticker: EVH) is a company listed on NYSE in the Healthcare sector (Health Information Services). It has approximately 4,500 employees. Market cap is $548M.

The current price is $4.8 with a P/E ratio of -1.03x and P/B of 1.32x.

ROE is -75.47% and operating margin is -1.06%. Annual revenue is $1.9B.